7151 - 7175 of 8587 Results
Title
Year
-
OPENTitle: The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and IIJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.994114Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.994114/pdfCitation Count: 4
- Adjuvant medical therapy in cervical dystonia after deep brain stimulation: A retrospective analysis2022OPENTitle: Adjuvant medical therapy in cervical dystonia after deep brain stimulation: A retrospective analysisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.927573Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.927573/pdfCitation Count: 3
-
OPENTitle: OnabotulinumtoxinA Dosing, Disease Severity, and Treatment Benefit in Patients With Cervical Dystonia: A Cohort Analysis From CD PROBEJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.914486Best OA location URL: https://doi.org/10.3389/fneur.2022.914486Citation Count: 7
- Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosis2022OPENTitle: Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.919778Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.919778/pdfCitation Count: 9
-
OPENTitle: Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesiaJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.846126Best OA location URL: https://doi.org/10.3389/fneur.2022.846126Citation Count: 5
-
OPENTitle: Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension StudyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.773999Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.773999/pdfCitation Count: 10
-
OPENTitle: The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development programJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.1036068Best OA location URL: https://doi.org/10.3389/fneur.2022.1036068Citation Count: 19
-
OPENTitle: Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.889647Best OA location URL: https://doi.org/10.3389/fneur.2022.889647Citation Count: 38
-
OPENTitle: Trends in the Utilization of Teleneurology and Other Healthcare Resources Prior to and During the COVID-19 Pandemic in an Urban, Tertiary Health SystemJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.834708Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.834708/pdfCitation Count: 9
-
OPENTitle: Editorial: Cannabinoids in neuroinflammation, neurodegeneration and pain: Focus on non-neuronal cellsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.1114775Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.1114775/pdfCitation Count: 1
-
OPENTitle: Editorial: LRRK2—Fifteen Years From Cloning to the ClinicJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.880914Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.880914/pdfCitation Count: 1
-
OPENTitle: Parkinson's disease resting tremor severity classification using machine learning with resampling techniquesJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.955464Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.955464/pdfCitation Count: 4
-
OPENTitle: Targeting the inflammasome in Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.957705Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.957705/pdfCitation Count: 17
-
OPENTitle: Sleepiness in Cognitively Unimpaired Older Adults Is Associated With CSF Biomarkers of Inflammation and Axonal IntegrityJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.930315Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.930315/pdfCitation Count: 15
-
OPENTitle: Plcg2M28L Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer’s Disease-Relevant Phenotypes in MiceJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.886575Best OA location URL: https://doi.org/10.3389/fnagi.2022.886575Citation Count: 17
-
OPENTitle: Sensor Measurements Can Characterize Fluctuations and Wearing Off in Parkinson’s Disease and Guide Therapy to Improve Motor, Non-motor and Quality of Life ScoresJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.852992Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.852992/pdfCitation Count: 11
-
OPENTitle: A Novel Tissue Atlas and Online Tool for the Interrogation of Small RNA Expression in Human Tissues and BiofluidsJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2022.804164Best OA location URL: https://doi.org/10.3389/fcell.2022.804164Citation Count: 13
-
OPENTitle: WHOPPA Enables Parallel Assessment of Leucine-Rich Repeat Kinase 2 and Glucocerebrosidase Enzymatic Activity in Parkinson’s Disease MonocytesJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2022.892899Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2022.892899/pdfCitation Count: 21
-
OPENTitle: Editorial: Non-neuronal cell heterogeneity in the nervous system during health and diseaseJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fncel.2022.1047296Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2022.1047296/pdfCitation Count: 1
-
OPENTitle: Current Status of Next-Generation Sequencing Approaches for Candidate Gene Discovery in Familial Parkinson´s DiseaseJournal Name: Frontiers in GeneticsPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fgene.2022.781816Best OA location URL: https://www.frontiersin.org/articles/10.3389/fgene.2022.781816/pdfCitation Count: 9
-
OPENTitle: Non-REM sleep with hypertonia in Parkinsonian Spectrum Disorders: A pilot investigationJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 100Issue #:Start Page: 501End Page: 510Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.sleep.2022.09.025Best OA location URL: https://escholarship.org/content/qt782393zz/qt782393zz.pdfCitation Count: 12
-
OPENTitle: Long-term adherence of human brain cells in vitro is enhanced by charged amine-based plasma polymer coatingsJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 17Issue #: 3Start Page: 489End Page: 506Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2022.01.013Best OA location URL: http://www.cell.com/article/S2213671122000571/pdfCitation Count: 15
-
OPENTitle: Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editingJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 62Issue #:Start Page: 102806End Page: 102806Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.scr.2022.102806Best OA location URL: https://doi.org/10.1016/j.scr.2022.102806Citation Count: 12
-
OPENTitle: Symptom Severity Mixity in Older-Age Bipolar Disorder: Analyses From the Global Aging and Geriatric Experiments in Bipolar Disorder Database (GAGE-BD)Journal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 30Issue #: 10Start Page: 1096End Page: 1107Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jagp.2022.03.007Best OA location URL: https://escholarship.org/content/qt38k068zm/qt38k068zm.pdfCitation Count: 16
-
OPENTitle: Llamanade: An open-source computational pipeline for robust nanobody humanizationJournal Name: StructurePublisher: Elsevier BVVol: 30Issue #: 3Start Page: 418End Page: 429.e3Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.str.2021.11.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11698024Citation Count: 32